Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Trichloroethylene chemical - widely used in industry - is a risk factor for parkinsonism

Parkinson's disease, the most common neurodegenerative movement disorder caused by aging, can also be caused by pesticides and other neurotoxins.

8 Jan 2008

Potential alternative to the existing smallpox vaccine

University of California, Irvine infectious disease researchers have shown the effectiveness of a potential alternative to the existing smallpox vaccine that can replace the current biodefense stockpile for this lethal virus.

8 Jan 2008

A look at China's most innovative health biotechnology companies

Government funds innovation but venture capital needed; Wary investors 'need to be shown the exits'; Returning 'sea turtles' bring expertise, international credibility

8 Jan 2008

Better access to cool caps improves outcomes, lowers cost of treating asphyxia in newborns

When newborns suffering from a form of asphyxia at birth have better access to head cooling devices, fewer will face a lifetime of debilitating and costly health complications, according to researchers at Beth Israel Deaconess Medical Center (BIDMC).

7 Jan 2008

Perrigo receives FDA OK for OTC Cetirizine Hydrochloride tablets

Perrigo Company has announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for over-the-counter (OTC) Cetirizine Hydrochloride Tablets, 5 and 10 mg.

2 Jan 2008

Novavax's new bird flu vaccine could bolster the arsenal against a pandemic

The drug company Novavax has announced that it's experimental avian flu vaccine has proved to be both safe and effective in Phase I/IIa trials in humans.

20 Dec 2007

Safer, more accurate, and more effective radiation therapy for pregnant women

Developing fetuses are extremely sensitive to radiation, which poses an impossible dilemma for expecting mothers in need of screening or treatment for cancer.

20 Dec 2007

Sensory Analytics receives new coating measurement patent

Sensory Analytics, an emerging leader in non-contact and non-destructive coating measurement systems, today announced the issuance of the company ' s third patent, United States Patent 7,274,463.

18 Dec 2007

Eli Lilly and BioMS Medical announce licensing and development agreement

Eli Lilly and Company and BioMS Medical Corp. have announced that the two companies have entered into a licensing and development agreement granting Lilly exclusive worldwide rights to BioMS Medical's lead multiple sclerosis (MS) compound, MBP8298.

18 Dec 2007

Agent orange chemical, dioxin, attacks the mitochondria to cause cancer

Researchers with the University of Pennsylvania School of Veterinary Medicine have demonstrated the process by which the cancer-causing chemical dioxin attacks the cellular machinery, disrupts normal cellular function and ultimately promotes tumor progression.

18 Dec 2007

Most powerful microscopes in the world

Seven new super-microscopes and a specially designed building will give scientists at DTU unique opportunities to design new materials.

10 Dec 2007

Myocor receives trial approval for percutaneously implanted iCoapsys system

Myocor, Inc. announced that the U.S. Food and Drug Administration has granted conditional approval of the Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) feasibility study.

5 Dec 2007

FDA issues approvable letter for Nebivolol for the treatment of hypertension

Forest Laboratories, Inc. and Mylan Inc. announced that Mylan has received an approvable letter from the U.S. Food and Drug Administration (FDA) in response to its New Drug Application (NDA) for nebivolol (proposed brand name Bystolic), a novel beta blocker under review for the treatment of hypertension.

2 Dec 2007

Influenza vaccine strategies for broad global access

If an influenza pandemic occurred this year, fewer than one-fifth of the approximately 13 billion vaccine doses needed to fully vaccinate the global population would be available within six months in a best-case scenario.

21 Nov 2007

Spectral announces license agreement with Bio-Rad Pasteur S.A.

Spectral Diagnostics Inc. has announced that it has entered into a non-exclusive license and material supply agreement with Bio-Rad Pasteur S.A., a leader in the manufacturing and distribution of a broad range of products for the life science research and clinical diagnostics markets.

20 Nov 2007

Schering-Plough acquires Organon BioSciences

Schering-Plough Corporation has announced that it has completed the acquisition of Organon BioSciences N.V., creating a stronger combined company with broader human and animal health portfolios, an enhanced pipeline and increased R&D capabilities. Schering-Plough's agreement to acquire Organon BioSciences was announced on March 12, 2007.

20 Nov 2007